US Bill Would Encourage Device Adverse-Event Reporting Experimentation
This article was originally published in SRA
Executive Summary
US senators have introduced a bill that parallels medical device industry-friendly sections of the 21st Century Cures Act that cleared the House of Representatives last year, but also adds something new: a provision to give Food Drug Administration more flexibility to pilot alternatives to the current adverse-event report process.